Link between rheumatoid arthritis and cancer;Der zusammenhang zwischen rheumatoider arthritis und krebs

Zeitschrift fur Rheumatologie

Volumn 65, Issue 6, 2006, Pages 497-504

  Whelan, P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Carcinogenesis; EBV; Hodgkin's lymphoma; Methotrexate; Non Hodgkin's lymphoma (NHL); Rheumatoid arthritis (RA); TNF

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CANCER; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPISCLERITIS; EPSTEIN BARR VIRUS; GENDER; HODGKIN DISEASE; HUMAN; LUNG NODULE; LYMPHOMA; PERICARDITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SKIN NODULE; VASCULITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMORBIDITY; CROSS-SECTIONAL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; NEOPLASMS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750309620     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0105-9     Document Type: Review

References (34)

1. Askling J, Fored CM, Baeklund E et al. (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis Epub Apr 20
2. Baecklund E, Ekborn A, Catrina AI et al. (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48: 1543-1550
3. Baecklund E, Illiadou A, Askling J et al. (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692-701
4. Balandraud N, Roudier J, Roudier C (2004) Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev 3: 362-367
5. Balandraud N, Roudier J, Roudier C (2005) What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis? Semin Arthritis Rheum 34 [Suppl 1]: 31-33
6. Bongartz T, Sutton AJ, Sweeting MJ et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275-2285
7. Bowman SJ (2002) Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 31: 251-259
8. Brown SL, Greene MH, Gershon SK et al. (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46: 3151-3158
9. Callan MF (2004) Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol 16: 399-405
10. Chakravarty E, Michaud K, Wolfe F (2005) Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 32: 2130-2135
11. Choi HK, Hernan MA, Seeger JD et al. (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359(9313): 1173-1177
12. Costenbader KH, Karlson EW (2006) Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 8: 204
13. Ekstrom K, Hjalgrim H, Brandt L et al. (2003) Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 48: 963-970
14. Fassbender HG, Gay S (1988) Synovial processes in rheumatoid arthritis. Scand J Rheum 76: 1-7
15. Firestein GS (1991) The immunopathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 3: 398-406
16. Franklin J, Lunt M, Bunn D et al. (2006) Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis. Ann Rheum Dis 65: 617-622 (Epub 2005 Oct 25)
17. Geborek P, Bladström A, Turesson C et al. (2005) Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64 [Suppl 4]: iv2-iv14 (Epub 2005 Feb 4)
18. Gridley G, McLaughlin JK, Ekbom A et al. (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 17: 307-311
19. Hoshida Y, Tomita J, Zhiming D et al. (2004) Lympho-proliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108: 443-449
20. Isomaki HA, Hakulinen T, Joutsenlahti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691-696
21. Karlson EW, Lee IM, Cook NR et al. (1999) A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42: 910-917
22. Louthrenoo W, Kasitanon N, Mahanuphab P et al. (2003) Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum 32: 326-333
23. Mariette X, Cazals-Hatem D, Warszawki J et al. (2002) Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909-3915
24. Mellemkjaer L, Linet MS (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 7: 1753-1757
25. Mikuls T, Endo JO, Puumala SE et al. (2006) Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis. J Clin Oncol 24: 1597-1602 (Epub 2006 Mar 6)
26. Prior P (1985) Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 78: 15-21
27. Salloum E, Cooper DL, Howe G et al. (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943-1949
28. Schiff MH, DiVittorio G, Tesser J et al. (2004) The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions. Arthritis Rheum 50: 1752-1760
29. Toussirot E, Wendling D, Tiberghien P et al. (2000) Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 59: 533-538
30. Varoczy L, Gergely L, Zeher M et al. (2002) Malignant lymphoma-associated autoimmune diseases - a descriptive epidemiological study. Rheumatol Int 22: 233-237 (Epub 2002 Aug 29)
31. Weyand C, Goronzy J, Kurtin P (2006) Lymphoma in rheumatoid arthritis: an immune system set up for failure. Arthritis Rheum 54: 685-689
32. Whelan J, Scadden D (2006) Cancer in the immunosuppressed patient. In: Chang AE (ed) Oncology: an evidence-based approach. Springer, New York
33. Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and antitumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50: 1740-1751
34. Yokochi T, Yamagawa A, Kimura Y et al. (1989) High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 16: 1029-1032